Analysis of the mRNA levels of B7 family members in CRC from the TCGA database also showed that B7-H3 exhibited the highest expression among B7 family members (Fig. 1B), indicating that B7-H3 may be a potential therapeutic target. This evidence concerns the gene CD276 and colorectal carcinoma.